Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01645176 · ClinicalTrials.gov registry record · Phase 2
Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee
A Phase 2 study of Osteoarthritis of the Knee, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT01645176 is a Phase 2 study of Osteoarthritis of the Knee that has completed, run by Stanford University. The registered enrollment target is 21 participants, below the 220-participant average among 15 other Osteoarthritis of the Knee trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01645176, a Phase 2 study of Osteoarthritis of the Knee, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study of a combination therapy of hydroxychloroquine and atorvastatin is to learn about the effects in inflammation and pain in patients with Osteoarthritis of the knee. These medications are FDA approved and commercially available.
Conditions Studied
Interventions
- DRUG Hydroxychloroquine/Atorvastatin
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01645176
The ClinicalTrials.gov registry entry for NCT01645176 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 220-participant average among 15 other Osteoarthritis of the Knee trials with a reported enrollment target (90% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis of the Knee appearing as the primary indexed condition, and to 1 intervention - of which Hydroxychloroquine/Atorvastatin is the first listed.
NCT01645176 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01645176 about?
NCT01645176 is a clinical study titled "Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee". The purpose of this study of a combination therapy of hydroxychloroquine and atorvastatin is to learn about the effects in inflammation and pain in patients with Osteoarthritis of the knee. These medications are FDA approved and commercially available.
What is the current status of trial NCT01645176?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2012-05. Estimated completion is 2016-10.
What conditions does trial NCT01645176 study?
This clinical trial studies the following conditions: Osteoarthritis of the Knee.
What interventions are being tested in trial NCT01645176?
The interventions under investigation include: Hydroxychloroquine/Atorvastatin (DRUG).
Who is sponsoring clinical trial NCT01645176?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01645176 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis of the Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
RECRUITING · Phase 2
-
A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis
COMPLETED · Phase 2
-
A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee
COMPLETED · Phase 2
-
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
COMPLETED · Phase 2
-
Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee
COMPLETED · Phase 2
-
Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.